Skip to content

Safety and effectiveness of sedation during and after diagnostic esophagogastroduodenoscopy: randomiszed comparisons between propofol and midazolam.

Safety and effectiveness of sedation during and after diagnostic esophagogastroduodenoscopy: randomiszed comparisons between propofol and midazolam. - The comparisons between propofol and midazolam for diagnostic esophagogastroduodenoscopy sedation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000009142
Enrollment
100
Registered
2012-10-18
Start date
2012-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper gastrointestinal disease

Interventions

Propofol Midazolam

Sponsors

Tokyo east hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Outpatients and inpatients of Tokyo east hospital or clinic adjacent to the hospital (Kikuchi geka-ichoka clinic).

Exclusion criteria

Exclusion criteria: Assigned to American Society of Anesthesiologists classes III and IV, severe liver dysfunction, pregnant, paresis after cerebral infarction, overweight (body weight > 100kg), allergic to the drug used or its components (soybeans or eggs), emergency procedure Others who could not accept this study concept or was estimated as inadequate for this study by the primary doctor

Design outcomes

Primary

MeasureTime frame
Safety: Vital signs, respiratory depression, full recovery (conscious level, motor function), the occurrence of adverse events within 24h after procedure Effectiveness: Overall satisfaction of procedures from patients' questionnaires

Secondary

MeasureTime frame
Successful procedure, depth of anesthesia, means of transfer after procedure and any other complications

Countries

Japan

Contacts

Public ContactHitoshi Kikuchi

Tokyo east hospital Surgery

hk14@mitsuwakai.jp0356363030

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026